Pharmaceutical Pricing Practices, Utilization and Costs - Meeting Summary. IV. Strategies for Controlling Costs and Increasing Value From Pharmaceutical Expenditures


The final session of the conference focused on the identification of strategies that might be adopted to control rising prescription drug expenditures and maximize the value for dollars spent on a pharmaceutical benefit. The session began with two formal presentations:

  • David Kreling, Ph.D., R.Ph., Sonderegger Research Center, School of Pharmacy, University of Wisconsin, described strategies that PBMs have adopted to control the costs of their customers' prescription drug programs.
  • Helene Levens Lipton, Ph.D., Institute for Health Policy Studies, Department of Clinical Pharmacy, University of California at San Francisco, reported on physician group practices' failed efforts to share financial risk for patients' drug costs with HMOs, as well as on hand-held, electronic prescribing devices.

The session also included a Panel Discussion and a "Lightning Round" of public policy researchers' perspectives.